Amphetamine aspartate monohydrate is a monohydrate form of the amphetamine aspartate salt, that is commonly used in combination with other amphetamine salts for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. Its therapeutic use is listed as ADHD agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Amphetamine Hemi-L-aspartate Hemihydrate, d and l-Amphetamine aspartate monohydrate. It is listed as a controlled drug substance (Schedule II). Its PubChem CID is 71587816.
Amphetamine aspartate monohydrate
| CAS No | 851591-76-9 |
|---|---|
| Molecular Formula | C22H35N3O5 |
| Molecular Weight | 421.5 g/mol |
| Synonyms | (2S)-2-aminobutanedioic acid;1-phenylpropan-2-amine;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Amphetamine aspartate monohydrate is a monohydrate form of the amphetamine aspartate salt, that is commonly used in combination with other amphetamine salts for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy.
The listed CAS number is 851591-76-9.
The listed molecular formula is C22H35N3O5.
The listed molecular weight is 421.5 g/mol.
(2S)-2-aminobutanedioic acid;1-phenylpropan-2-amine;hydrate.
The source lists Amphetamine Hemi-L-aspartate Hemihydrate, d and l-Amphetamine aspartate monohydrate.